March 29, 2019
Janssen Pharmaceutical said on March 28 that it has filed its anti-IL-12/23 p40 monoclonal antibody Stelara (ustekinumab) in Japan for an additional indication of ulcerative colitis (UC), aiming to expand its label, which currently covers psoriasis and Crohn’s disease. Stelara...read more